MSL2
MSL2geneMSL2 participates in circadian and metabolic regulation; associated with CAD risk via sleep-duration-dependent mechanisms off the atherothrombotic axis.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencelow
RationaleDosage compensation; systemic circadian/metabolic stress pathway.
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000174579
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Human genetic evidence
1
GWAS associations
Traits: myocardial infarction
Literature evidence(1)
- Identification of genetic loci jointly influencing coronary artery disease risk and sleep traits of insomnia, sleep duration, and chronotype.Sleep medicine · 2020 · PMID 32846279 · doi